Cardiac Markers: An Index in the Assessment of Cardiovascular Disease in Diabetic Patients in Bayelsa State, Niger Delta Region, South of Nigeria — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Cardiac Markers: An Index in the Assessment of Cardiovascular Disease in Diabetic Patients in Bayelsa State, Niger Delta Region, South of Nigeria
Department of Medical Laboratory Science (Chemical Pathology Unit), Faculty of Basic Medical Sciences, College of Health Sciences, Niger Delta University, Amasoma, Nigeria
1 Department of Medical Laboratory Science (Chemical Pathology Unit), Faculty of Basic Medical Sciences, College of Health Sciences, Niger Delta University, Amasoma, Nigeria
Background and Objective: Patients with type 2 Diabetes mellitus (DM) are known to be at risk of developing cardiovascular diseases (CVD). The prevalence and incidence of DM patients with heart diseases is unknown in Yenagoa and its environ of Bayelsa State, Niger Delta Region of Nigeria. The study, with the tool of cardiac markers, investigated the incidence of CVD in chronic and non-chronic DM patients and compared the prevalence in both male and female subjects with respect to the duration of illness. The study sought to evaluate the diagnostic performance of cardiac markers to evaluate the diabetic subjects and the goals of screening are to improve life expectancy and quality of life by preventing Myocardial infarction (MI) and heart failure through the early detection of significant CVD. Study Design and Methods: A total of 356 type 2 DM patients were recruited for the study. They are diabetic patients that presented with symptoms of CVD. They were grouped into 135 DM patients that have suffered the Diabetes for less than 10 years, 119 for 10 - 20 years and 102 for 21 and above years. The plasma levels of the Cardiac Markers, Troponin I (CTnI), Troponin T (cTnT), Creatine Kinase (CK-MB), Myoglobin (MYO) and Lactate dehydrogenase (LDH) were determined in the subjects. The method of fluorescence immunoassay (FIA) was used in the measurement of CTn1, CTnT and MYO. Enzyme Linked Immunosorbent Assay (ELISA) was used to determine the CK-MB and LDH. Results: Analysis of the results has shown that 14.33% of the studied subjects were diagnosed of various CVD and were statistically significant (p < 0.05). Of these, 8.15% were females and 6.18% were males. 54.90% of DM subjects diagnosed of CVD were from group 21 and above years while 29.41% were from group 10 to 20 years and 15.69% from those that had suffered it for <10 years. 26.12% of the total DM patients studied had either one or more of the cardiac markers elevated, showing the potentials of developing heart diseases. The correlation between the different age groups and the pair wise correlations between measured parameters in the DM patients with CVD showed a positive correlation. Conclusion: The tools of cardiac markers can be used in the diagnosis/assessment of CVD in type 2 DM patients. The risk of developing CVD is more in females than the male subjects that are suffering from type 2 DM and those with long duration of the illness in Yenegoa, Bayelsa State, Niger Delta Region, South of Nigeria.
Ceriello, A. and Motz, E. (2004) Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes and Cardiovascular Disease? The Common Soil Hypothesis Revisited. Artherioselerosis, Thrombosis and Vascular Biology, 24, 329-333. https://doi.org/10.1161/01.ATV.0000122852.22604.78
Briggs, O.N., Brown, H., Elechi-Amadi, K., Ezeiruaku, F. and Nduka, N. (2016) Superoxide Dismutase and Glutathione Peroxide Levels in Patients with Long Standing Type 2 Diabetes in Port-Harcourt, Rivers State, Nigeria. International Journal of Science and Research, 5, 1282-1288. https://doi.org/10.21275/v4i5.NOV162149
Ezeiruaku, F.C., Wankasi, M.M. and George, G.S. (2016) The Antioxidant Enzymes (Superoxide Dismutase; Glutathione Peroxidase: Catalase) Satatus in Chronic and Non-Chronic Diabetes Mellitus Type 1 and 2 Subjects in Yenagoa, Bayelsa State, Nigeria. Journal of Biology and Genetic Research, 2, 35-45.
Giacco, F. and Brownlee, M. (2010) Oxidative Stress and Diabetes Complications. Circulation Research, 107, 1058-1070. https://doi.org/10.1161/CIRCRESAHA.110.223545
Stevens, R.J., Kothari, V., Adler, A.I., et al. (2001) The UKPDS Risk Engine: A Model for the Risk of Coronary Heart Disease in Type II Diabetes (UKPDS56). Clinical Science, 101, 671-681. https://doi.org/10.1042/cs1010671
Vistisen, D., Anderson, G.S., Hanson, C.S., et al. (2016) Prediction of Trist Cardiovascular Disease Event in Type 1 Diabetes Mellitus. The Stenotype 1 Risk Engine. Circulation, 133, 1058-1069. https://doi.org/10.1161/CIRCULATIONAHA.115.018844
Sarwar, N., Gao, P., et al. (2010) Diabetes Mellitus, Fasting Blood Glucose Concentration and Risk of Vascular Disease: A Collaborative Meta-Analysis of 102 Prospective Studies. The Lancet, 375, 2215-2225. https://doi.org/10.1016/S0140-6736(10)60484-9
Booth, G.L., Kapral, M.K., Fung, K., et al. (2006) Relation between Age and Cardiovascular Disease in Men and Women with Diabetes Compared with Non Diabetic People. A Population-Based Retrospective Cohort Study. The Lancet, 368, 29-36. https://doi.org/10.1016/S0140-6736(06)68967-8
Cohn, P.F., Fox, K.M. and Daly, C. (2003) Silent Myocardial Ischemia. Circulation, 108, 1263-1277. https://doi.org/10.1161/01.CIR.0000088001.59265.EE
Carson, A.P., Tanner, R.M., Yun, H., et al. (2014) Declines in Coronary Heart Disease Incidence and Mortality among Middle-Aged Adults with and without Diabetes. Annals of Epidemiology, 24, 581-590. https://doi.org/10.1016/j.annepidem.2014.05.007
Myoglobin
Lactate Dehydrogenase
Immunoassay
Wannamethee, S.G., Shaper, A.G. and Lennon, L. (2004) Cardiovascular Disease Incidence and Mortality in Older Men with Diabetes and in Men with Coronary Heart Disease. Heart, 90, 1398-1410. https://doi.org/10.1136/hrt.2003.026104
Secrest, A.M., Becker, D.J., Kelsey, S.F., et al. (2010) Cause-Specific Mortality Trends in a Large Population Based Cohort with Long-Standing Childhood-Onset Type 1 Diabetes. Diabetes, 59, 3216-3223. https://doi.org/10.2337/db10-0862
Victor, M., Ezekiel, U.N., Timothy, C.B., et al. (2015) Prevalence of Cardiovascular Disease Risk Factors among a Nigeria Adult Population. Relationship with Income Level and Accessibility to CVD Risks Screening. BMC Public Health, 15, 397-406. https://doi.org/10.1186/s12889-015-2101-y
World Health Organisation (WHO) (2018) Non-Communicable Disease (NCD) Country Profiles.
Bwititi, P.T. and Nwose, E.U. (2014) Screening of Cardiovascular Disease Risk in Diabetes: Questions Concerning Pre-Diabetes and Low-Mid Income Countries. North American Journal of Medical Sciences, 6, 284-286. https://doi.org/10.4103/1947-2714.134376
Nick, T., Lauren, W., Prachi, B., et al. (2016) Cardiovascular Disease in Europe: Epidemiological Update 2016. European Heart Journal, 37, 3232-3245. https://doi.org/10.1093/eurheartj/ehw334
World Health Organisation (2018) WHO Mortality Database, Geneva, Switzerland. World Health Organisation, Development of Health Statistics and Information System 2015. https://www.who.int/healthinfo/statistics/en/
Newby, L.K., Storrow, A.B., Gibler, W.B., et al. (2001) Bedside Multimarker Testing for Risk Stratification in Chest Pain Units: The Chest Pain Evaluation by Creatine Kinase-MB, Myoglobin and Troponin 1 Study. Circulation, 103, 1832-1837. https://doi.org/10.1161/01.CIR.103.14.1832
Wu, A.H. and Jaffe, A.S. (2008) The Clinical Need for High-Sensitivity Cardiac Troponin Assays for Acute Coronary Syndromes and the Role for Serial Testing. American Heart Journal, 155, 208-214. https://doi.org/10.1016/j.ahj.2007.10.016
Morrow, D.A., Cannon, C.P., Rifai, N., et al. (2001) Ability of Minor Elevations of Troponins 1 and T to Predict Benefit from an Early Invasive Strategy in Patients with Unstable Angina and Non-ST Elevation Myocardial Infarction: Results from a Randomized Trial. JAMA, 286, 2405-2412. https://doi.org/10.1001/jama.286.19.2405
Morrow, D.A. and Antman, E.M. (2009) Evaluation of High-Sensitivity Assays for Cardiac Troponin. Clinical Chemistry, 55, 5-8. https://doi.org/10.1373/clinchem.2008.117218
Kavsak, P.A., MacRae, A.R., Newman, A.M., et al. (2007) Effects of Contemporary Troponin Assay Sensitivity on the Utility of the Early Markers Myoglobin and CKMB Isoforms in Evaluating Patients with Possible Acute Myocardial Infarction. Clinica Chimica Acta, 380, 213-216. https://doi.org/10.1016/j.cca.2007.01.001
Eggers, K.M., Oldgren, J., Nordenskjold, A. and Lindahl, B. (2004) Diagnostic Value of Serial Measurement of Cardiac Markers in Patients with Chest Pain: Limited Value of Adding Myoglobin to Troponin 1 for Exclusion of Myocardial Infarction. American Heart Journal, 148, 574-581. https://doi.org/10.1016/j.ahj.2004.04.030
Martins, J.T., Li, D.J., Baskin, L.B., Jialal, I. and Keffer, J.H. (1996) Comparison of Cardiac Troponin 1 and Lactate Dehydrogenase Isoenzymes for the Late Diagnosis of Myocardial Injury. American Journal of Clinical Pathology, 106, 705-708. https://doi.org/10.1093/ajcp/106.6.705
Adedoyin, R.A. and Adesoye, A.T. (2005) Incidence and Pattern of Cardiovascular Disease in Nigerian Hospital. Tropical Doctor, 35, 104-106. https://doi.org/10.1258/0049475054037075
Ekpenyong, C.E., Udokang, N.E., Akpan, E.E. and Sampson, T.K. (2012) Double Burden, Non-Communicable Diseases and Risk Factors Evaluation in Sub-Saharan African. The Nigerian Experience. European Journal of Sustainable Development, 1, 249-270.
Vivek, N.A., Sharma, Y.V. and Somani, B.L. (1998) Methods for Estimation of Blood Glucose: A Comparative Evaluation. Medical Journal Armed Forces India, 54, 131-133. https://doi.org/10.1016/S0377-1237(17)30502-6
Ohman, E.M., Armstrong, P.W., Christenson, R.H., et al. (1996) Cardiac Troponin Levels for Risk Stratification in Acute Myocardial Ischemia. The New England Journal of Medicine, 335, 1333-1341. https://doi.org/10.1056/NEJM199610313351801
Antman, E.M., Tanasijevic, M.J., Thompson, B., et al. (1996) Cardiac Specific Troponin 1 Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes. The New England Journal of Medicine, 335, 1342-1349. https://doi.org/10.1056/NEJM199610313351802
Uotila, M., Ruosiahti, E. and Engrall, E. (1981) Enzyme Linked Immunoassays. Journal of Immunological Method, 42, 11-15. https://doi.org/10.1016/0022-1759(81)90219-2
Stephanie, A.C. (2011) Epidemiology of Cardiovascular Disease in Women. Texas Heart Institute Journal, 38, 145-147.
Huvely, R., Barzi, F. and Woodward, M. (2006) Excess Risk of Fatal Coronary Heart Disease Associated with Diabetes in Men and Women: Meta-Analysis of 37 Prospective Cohort Studies. BMJ, 332, 73-78. https://doi.org/10.1136/bmj.38678.389583.7C
Alessandra, S., Lucianne, R., Roberts, A., Catia, C., Carlos, A. and Marilia de Brito, G. (2013) Impart of Diabetes on Cardiovascular Disease: An Update. International Journal of Hypertension, 2013, Article ID: 653789.
Bulugahapitiya, U., Siyambalapitiya, S., Sithole, J. and Idris, I. (2009) Is Diabetes a Coronary Risk Equivalent? Systematic Review and Meta-Analysis. Diabetic Medicine, 26, 142-148. https://doi.org/10.1111/j.1464-5491.2008.02640.x